Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose of this study was to evaluate the ability of multiparametric assay to correctly classify patients with multiple CTDs and healthy controls (HC), independent of clinical features, and to evaluate whether serological status could identify clusters of patients with similar clinical features.
METHODS: Patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogren's syndrome (SjS), undifferentiated connective tissue disease (UCTD), idiopathic inflammatory myopathies (IIM) and HC were enrolled. Serum was tested for 29 autoantibodies. An XGBoost model, exclusively based on autoantibody titres was built and classification accuracy was evaluated. A hierarchical clustering model was subsequently developed and clinical/laboratory features compared among clusters.
RESULTS: 908 subjects were enrolled. The classification model showed a mean accuracy of 60.84±4.05% and a mean area under the receiver operator characteristic curve of 88.99±2.50%, with significant discrepancies among groups. Cluster analysis identified four clusters (CL). CL1 included patients with typical features of SLE. CL2 included most patients with SjS, along with some SLE and UCTD patients with SjS-like features. CL4 included anti-Jo1 patients only. CL3 was the largest and most heterogeneous, including all the remaining subjects, overall characterised by low titre or lower-prevalence autoantibodies.
CONCLUSION: Extended multiparametric autoantibody assay allowed an accurate classification of CTD patients, independently of clinical features. Clustering according to autoantibody titres is able to identify clusters of CTD subjects with similar clinical features, independently of their final diagnosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
RMD open - 9(2023), 3 vom: 21. Sept. |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Autoantibodies |
|---|
| Anmerkungen: |
Date Completed 25.09.2023 Date Revised 11.10.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/rmdopen-2023-003365 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362314705 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362314705 | ||
| 003 | DE-627 | ||
| 005 | 20231226090959.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/rmdopen-2023-003365 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1207.xml |
| 035 | |a (DE-627)NLM362314705 | ||
| 035 | |a (NLM)37734871 | ||
| 035 | |a (PII)e003365 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cafaro, Giacomo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2023 | ||
| 500 | |a Date Revised 11.10.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a OBJECTIVE: Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose of this study was to evaluate the ability of multiparametric assay to correctly classify patients with multiple CTDs and healthy controls (HC), independent of clinical features, and to evaluate whether serological status could identify clusters of patients with similar clinical features | ||
| 520 | |a METHODS: Patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogren's syndrome (SjS), undifferentiated connective tissue disease (UCTD), idiopathic inflammatory myopathies (IIM) and HC were enrolled. Serum was tested for 29 autoantibodies. An XGBoost model, exclusively based on autoantibody titres was built and classification accuracy was evaluated. A hierarchical clustering model was subsequently developed and clinical/laboratory features compared among clusters | ||
| 520 | |a RESULTS: 908 subjects were enrolled. The classification model showed a mean accuracy of 60.84±4.05% and a mean area under the receiver operator characteristic curve of 88.99±2.50%, with significant discrepancies among groups. Cluster analysis identified four clusters (CL). CL1 included patients with typical features of SLE. CL2 included most patients with SjS, along with some SLE and UCTD patients with SjS-like features. CL4 included anti-Jo1 patients only. CL3 was the largest and most heterogeneous, including all the remaining subjects, overall characterised by low titre or lower-prevalence autoantibodies | ||
| 520 | |a CONCLUSION: Extended multiparametric autoantibody assay allowed an accurate classification of CTD patients, independently of clinical features. Clustering according to autoantibody titres is able to identify clusters of CTD subjects with similar clinical features, independently of their final diagnosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Sjogren's syndrome | |
| 650 | 4 | |a autoimmune diseases | |
| 650 | 4 | |a lupus erythematosus, systemic | |
| 650 | 4 | |a scleroderma, systemic | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 700 | 1 | |a Bartoloni, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Baldini, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Franceschini, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Riccieri, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Fioravanti, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Fornaro, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Ghirardello, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Palterer, Boaz |e verfasserin |4 aut | |
| 700 | 1 | |a Infantino, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Rigon, Amelia |e verfasserin |4 aut | |
| 700 | 1 | |a Del Rosso, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Gerli, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Villalta, Danilo |e verfasserin |4 aut | |
| 700 | 1 | |a Bizzaro, Nicola |e verfasserin |4 aut | |
| 700 | 0 | |a FIRMA (Interdisciplinary Forum for the Research on Autoimmune Diseases) Collaborators |e verfasserin |4 aut | |
| 700 | 0 | |a FIRMA Collaborators |e verfasserin |4 aut | |
| 700 | 1 | |a Bistoni, Onelia |e investigator |4 oth | |
| 700 | 1 | |a Perricone, Carlo |e investigator |4 oth | |
| 700 | 1 | |a Topini, Fabiana |e investigator |4 oth | |
| 700 | 1 | |a Sebastiano, Manuela |e investigator |4 oth | |
| 700 | 1 | |a Migliorini, Paola |e investigator |4 oth | |
| 700 | 1 | |a Piantoni, Silvia |e investigator |4 oth | |
| 700 | 1 | |a Cavazzana, Ilaria |e investigator |4 oth | |
| 700 | 1 | |a Fredi, Micaela |e investigator |4 oth | |
| 700 | 1 | |a Masneri, Stefania |e investigator |4 oth | |
| 700 | 1 | |a Garrafa, Emirena |e investigator |4 oth | |
| 700 | 1 | |a Bellisai, Francesca |e investigator |4 oth | |
| 700 | 1 | |a Cheleschi, Sara |e investigator |4 oth | |
| 700 | 1 | |a Bacarelli, Maria-Romana |e investigator |4 oth | |
| 700 | 1 | |a Tampoia, Marilina |e investigator |4 oth | |
| 700 | 1 | |a Zen, Margherita |e investigator |4 oth | |
| 700 | 1 | |a Parronchi, Paola |e investigator |4 oth | |
| 700 | 1 | |a Cammelli, Daniele |e investigator |4 oth | |
| 700 | 1 | |a Benucci, Maurizio |e investigator |4 oth | |
| 700 | 1 | |a Manfredi, Mariangela |e investigator |4 oth | |
| 700 | 1 | |a Giacomelli, Roberto |e investigator |4 oth | |
| 700 | 1 | |a Arcarese, Luisa |e investigator |4 oth | |
| 700 | 1 | |a Querini, Patrizia Rovere |e investigator |4 oth | |
| 700 | 1 | |a Canti, Valentina |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t RMD open |d 2015 |g 9(2023), 3 vom: 21. Sept. |w (DE-627)NLM254089658 |x 2056-5933 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g number:3 |g day:21 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/rmdopen-2023-003365 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2023 |e 3 |b 21 |c 09 | ||